title: [Screening of cervix uteri cancer in female health workers. Comparative analysis of insured individuals].
abstract: OBJECTIVE
  To compare epidemiological characteristics and proportion of participation in a cervical cancer screening program in both, health-care professionals and insured on a health institute's women (Group A and Group B respectively).
  
  
  METHODS
  Through questionnaires applied to both healthcare professionals and insured on a health institute's women (n = 96 for each group) randomly selected, a cross-sectional study was performed. To analyze the results, Yates' correction for continuity, was used.
  
  
  RESULTS
  The characteristics from A and B groups were respectively: age 35 +/- 10 vs. 41 +/- 5 years (p < 0.001), years of scholarship: 8.3 +/- 5 vs. 12.0 +/- 1 (p < 0.001), frequency of screening test in the last two years: 1.2 +/- 0.4 vs. 1.0 +/- 0.1 (p < 0.001), time elapsed from the last test: 13.6 +/- 15 vs. 12.2 +/- 13 months (p = 0.52), attendance to screening test 55 (57%) vs. 72 (75%), (p < 0.001). Reasons for not attendance to screening test were indolence 13 (14%) vs. 13 (14%) and not enough time 7 (7%) vs. 2 (2%) by both groups, A and B, respectively.
  
  
  CONCLUSIONS
  The proportion of attendance to cervical cancer screening is higher in health-care professionals than in insured on a health institute's women. The causes for not attendance to screening are the same in both groups.
authors.affiliation: Hospital General de Zona y Medicina Familiar (HGZ y MF) No. 1 IMSS, Colima.
authors.forename: M G
authors.initials: MG
authors.lastname: Alvarez-González
authors.forename: L
authors.initials: L
authors.lastname: Cernas-Reyes
authors.forename: C E
authors.initials: CE
authors.lastname: Tene Pérez
authors.forename: B
authors.initials: B
authors.lastname: Trujillo-Hernández
mesh_terms: D000293:Adolescent; D000328:Adult; D003430:Cross-Sectional Studies; D005260:Female; D006282:Health Personnel; D006801:Humans; D008403:Mass Screening; D008875:Middle Aged; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*